Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 2/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | HCAR1 | Q9BXC0 | 2/20 | 0.32 |
| ▸ | BTK | Q06187 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22307199 | 0.67 | PDCD1 (0.45) | — | |
| SCHEMBL22308215 | 0.67 | EGFR (0.33) | NSD2EGFRERBB2ADORA2A | |
| SCHEMBL29372980 | 0.67 | PDCD1 (0.45) | — | |
| SCHEMBL30522700 | 0.67 | PDCD1 (0.35) | NSD2EGFRERBB2ADORA2A | |
| SCHEMBL29473089 | 0.67 | EGFR (0.33) | NSD2EGFRERBB2ADORA2A | |
| SCHEMBL28486432 | 0.67 | PDCD1 (0.35) | NSD2EGFRERBB2ADORA2A | |
| SCHEMBL31521787 | 0.67 | HPGD (0.41) | HCAR1 | |
| SCHEMBL23726028 | 0.64 | JAK2 (0.39) | BTK | |
| SCHEMBL31220245 | 0.63 | NSD2 (0.34) | NSD2 | |
| SCHEMBL25171876 | 0.63 | NSD2 (0.34) | NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113365995-B | Immunomodulators, compositions and methods thereof | 贝达药业股份有限公司 | 2025-03-04 | — | — | CN | disclosed |